IXC.AX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 04:16):

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial...

Stats
Dzisiejszy wolumen	17 121.00
Średni wolumen	38 934.00
Kapitalizacja rynkowa	6.31M
EPS	$0 ( 2024-02-16 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.050
ATR14	$0 (0.00%)

Invex Therapeutics Ltd Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Invex Therapeutics Ltd Finanse

Annual	2023
Przychody:	$459 085
Zysk brutto:	$459 085 (100.00 %)
EPS:	$-0.100

FY	2023
Przychody:	$459 085
Zysk brutto:	$459 085 (100.00 %)
EPS:	$-0.100

FY	2022
Przychody:	$182 251
Zysk brutto:	$182 251 (100.00 %)
EPS:	$-0.0526

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.0407

Financial Reports:

No articles found.

Invex Therapeutics Ltd